← Back to Clinical Trials
Recruiting NCT05500755

NCT05500755 Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05500755
Status Recruiting
Phase
Sponsor Aula Dental Avanzada
Condition Dental Implants
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2022-07-29
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type OBSERVATIONAL
Interventions
Implant Treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2022-07-29 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.

Eligibility Criteria

Inclusion Criteria: * All the patients whom received at least one DS Prime Taper implant. Exclusion Criteria: * When dental implant surgery is contraindicated.

Contact & Investigator

Central Contact

Guillem Esteve-Pardo, PhD

✉ guillem@clinicaesteve.com

📞 +34965215755

Principal Investigator

Guillem Esteve-Pardo, PhD

PRINCIPAL INVESTIGATOR

Clínica Dental Esteve

Frequently Asked Questions

Who can join the NCT05500755 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Dental Implants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05500755 currently recruiting?

Yes, NCT05500755 is actively recruiting participants. Contact the research team at guillem@clinicaesteve.com for enrollment information.

Where is the NCT05500755 trial being conducted?

This trial is being conducted at Alicante, Spain.

Who is sponsoring the NCT05500755 clinical trial?

NCT05500755 is sponsored by Aula Dental Avanzada. The principal investigator is Guillem Esteve-Pardo, PhD at Clínica Dental Esteve. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology